William Wilkison, Chief Scientific Officer, Director, and 10% Owner of Vogenx, Inc., filed a Form 4 on November 20, 2026, reporting the exercise of stock options and resulting changes in beneficial ownership as of November 18, 2026.

Key Highlights

  • Transaction date: November 18, 2026, involving 5,900 shares of Common Stock acquired via option exercise (transaction code M).
  • Exercise price: $1.03 per share for the Stock Option (Right to Buy).
  • Direct ownership after transaction: 5,900 shares of Common Stock held directly, with the option exercised at a price of $0 for the derivative security.
  • Indirect ownership: 1,800,000 shares of Common Stock held indirectly through WOWIG, LLC, of which Wilkison is the sole member.
  • Remaining derivative securities: 110,766 stock options (Right to Buy) beneficially owned directly following the transaction, with an expiration date of July 27, 2027.
  • Option status: According to the filing, "The shares subject to this option are fully vested and exercisable as of the date hereof."

Wilkison Option Exercise and Ownership Details at Vogenx

According to the Form 4 filed with the SEC, William Wilkison, serving as Chief Scientific Officer, Director, and 10% Owner of Vogenx, Inc. (NASDAQ:VOGX), reported a transaction dated November 18, 2026. The filing discloses that Wilkison acquired 5,900 shares of Common Stock through the exercise of a Stock Option (Right to Buy), with a conversion or exercise price of $1.03. The transaction is coded M, indicating an exercise or conversion of a derivative security.

Following the reported transaction, Wilkison directly holds 5,900 shares of Common Stock. In addition, the filing reports 1,800,000 shares of Common Stock held indirectly, with the nature of that indirect beneficial ownership attributed to WOWIG, LLC. The filing states that Wilkison is the sole member of WOWIG, LLC, which is the direct owner of those securities.

In Table II, the filing records that 5,900 derivative securities (Stock Options with a Right to Buy) were disposed of under transaction code M on November 18, 2026, with an expiration date of July 27, 2027. The price of the derivative security is listed as $0. Following the transaction, Wilkison beneficially owns 110,766 stock options directly. The filing notes that the exercised options were fully vested and exercisable as of the transaction date.

What Was Disclosed

Wilkison's Form 4 discloses a November 18, 2026 exercise of 5,900 stock options at $1.03 per share in Vogenx, Inc., resulting in direct ownership of 5,900 Common Stock shares, indirect ownership of 1,800,000 shares via WOWIG, LLC, and 110,766 remaining stock options held directly.